Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis

INTRODUCTION: Besides their blood pressure-lowering effects, olmesartan medoxomil and amlodipine besylate exhibit additional anti-inflammatory mechanisms in atherosclerosic disease. Most of the studies investigating the effects of atherosclerosis focused on early atherosclerotic lesions, whereas les...

Descripción completa

Detalles Bibliográficos
Autores principales: Sievers, Philipp, Uhlmann, Lorenz, Korkmaz-Icöz, Sevil, Fastner, Christian, Bea, Florian, Blessing, Erwin, Katus, Hugo A, Preusch, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524379/
https://www.ncbi.nlm.nih.gov/pubmed/26251572
http://dx.doi.org/10.2147/DDDT.S85203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524379/
https://www.ncbi.nlm.nih.gov/pubmed/26251572
http://dx.doi.org/10.2147/DDDT.S85203

Ejemplares similares